Table 4.
Univariate analysis for factors predicting refractory anastomotic strictures after TE
| Refractory anastomotic strictures | P-value | ||
|---|---|---|---|
| Negative (n = 69) | Positive (n = 6) | ||
| Age (years) | 61.4 ± 8.2 | 59.0 ± 6.4 | N.S. |
| Gender (Male, Female) | 51, 18 | 6, 0 | N.S. |
| BMI | 21.4 ± 2.7 | 21.1 ± 2.7 | N.S. |
| Preoperative chemotherapy | 39 (56.5%) | 2 (33.3%) | N.S. |
| TNM Stage (I, II, III, IV) | 27, 16, 22, 4 | 1, 4, 1, 0 | N.S. |
| Total operation time (min) | 604 ± 113 | 606 ± 116 | N.S. |
| Operation time of thoracic surgery (min) | 331 ± 75 | 329 ± 55 | N.S. |
| Blood loss (g) | 380 (303–623) | 340 (200–500) | N.S. |
| Blood Transfusion | 6 (8.7%) | 1 (16.7%) | N.S. |
| 3-field lymph node dissection | 22 (29.3%) | 1 (16.7%) | N.S. |
| Paroxysmal atrial fibrillation | 12 (17.4%) | 1 (16.7%) | N.S. |
| Vasopressor agents | 7 (10.1%) | 1 (16.7%) | N.S. |
| WBC (10^3/μl) at 1POD | 9.7 (8.2–12.8) | 8.9 (7.0–11.5) | N.S. |
| CRP (10^4 μg/L) at 1POD | 9.0 ± 2.3 | 10.9 ± 3.6 | N.S. |
| Lactic acid (mmol/L) at 1POD | 1.4 (1.1–1,8) | 2.1 (1.2–2.7) | N.S. |
| CPK (IU/L) at 1POD | 890 (620–1309) | 1214 (675–2041) | N.S. |
| Postoperative hospital stay (days) | 20 (20–35) | 41 (25–61) | N.S. |